Gene expression: Biomarker of antidepressant therapy?

International Review of Psychiatry

Volumn 25, Issue 5, 2013, Pages 579-591

  Menke, Andreas ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DOCOSAHEXAENOIC ACID; ESCITALOPRAM; FK 506 BINDING PROTEIN; FLUOXETINE; PAROXETINE; REBOXETINE; VENLAFAXINE;

ARTICLE; DEPRESSION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; MAJOR DEPRESSION; MICROARRAY ANALYSIS; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NEUROTRANSMISSION; PRIORITY JOURNAL; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TARGET ORGAN; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; GENE EXPRESSION; HUMANS; PHARMACOGENETICS;

EID: 84886686112     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.825580     Document Type: Article

References (118)

1. Allan, L.L., Hoefl, K., Zheng, D.J., Chung, B.K., Kozak, F.K., Tan, R. & van den Elzen, P. (2009). Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood, 114, 2411-2416.
2. Andres, J.I., Alcazar, J., Alonso, J.M., Alvarez, R.M., Bakker, M.H., Biesmans, I., ? Steckler, T. (2005). Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity. Journal of Medicinal Chemistry, 48, 2054-2071.
3. Angelucci, F., Croce, N., Spalletta, G., Dinallo, V., Gravina, P., Bossu, P., ? Bernardini, S. (2011). Paroxetine rapidly modulates the expression of brain-derived neurotrophic factor mRNA and protein in a human glioblastoma-astrocytoma cell line. Pharmacology, 87, 5-10.
4. Angst, J. (1961). A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations. Psychopharmacologia, 2, 381-407.
5. Audinot, V., Mailliet, F., Lahaye-Brasseur, C., Bonnaud, A., Le Gall, A., Amosse, C., ? Boutin, J.A. (2003). New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 367, 553-561.
6. Baird, A.E. (2006). The blood option: Transcriptional profiling in clinical trials. Pharmacogenomics, 7, 141-144.
7. Barbon, A., Orlandi, C., La Via, L., Caracciolo, L., Tardito, D., Musazzi, L., ? Barlati, S. (2011). Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology, 63, 160-168.
8. Barreto, R.A., Walker, F.R., Dunkley, P.R., Day, T.A. & Smith, D.W. (2012). Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression? BMC Neuroscience, 13, 125.
9. Beech, R.D., Lowthert, L., Leffert, J.J., Mason, P.N., Taylor, M.M., Umlauf, S., ? Bhagwagar, Z. (2010). Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disorders, 12, 813-824.
10. Belzeaux, R., Bergon, A., Jeanjean, V., Loriod, B., Formisano-Treziny, C., Verrier, L., ? Ibrahim, E.C. (2012). Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Translational Psychiatry, 2, e185.
11. Belzeaux, R., Formisano-Treziny, C., Loundou, A., Boyer, L., Gabert, J., Samuelian, J. C., ? Ibrahim, E.C. (2010). Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. Journal of Psychiatric Research, 44, 1205-1213.
12. Binder, E.B. (2009). The role of FKBP5, aco-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology, 34, S186-195.
13. Binder, E.B. & Holsboer, F. (2006). Pharmacogenomics and antidepressant drugs. Annals of Medicine, 38, 82-94.
14. Blendy, J.A. (2006). The role of CREB in depression and antidepressant treatment. Biological Psychiatry, 59, 1144-1150.
15. Borovecki, F., Lovrecic, L., Zhou, J., Jeong, H., Then, F., Rosas, H.D., ? Krainc, D. (2005). Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America, 102, 11023-11028.
16. Calabrese, F., Molteni, R., Gabriel, C., Mocaer, E., Racagni, G. & Riva, M.A. (2011). Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine. Psychopharmacology (Berlin), 215, 267-275.
17. Calabrese, F., Molteni, R., Racagni, G. & Riva, M.A. (2009). Neuronal plasticity: A link between stress and mood disorders. Psychoneuroendocrinology, 34, S208-216.
18. Carlezon, W.A., Jr, Duman, R.S. & Nestler, E.J. (2005). The many faces of CREB. Trends in Neurosciences, 28, 436-445.
19. Castren, E. & Rantamaki, T. (2010). The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Developmental Neurobiology, 70, 289-297.
20. Cattaneo, A., Bocchio-Chiavetto, L., Zanardini, R., Milanesi, E., Placentino, A. & Gennarelli, M. (2010). Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. International Journal of Neuropsychopharmacology , 13, 103-108.
21. Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K.J., ? Pariante, C.M. (2013). Candidate genes expression profile associated with antidepressants response in the GENDEP study: Differentiating between baseline ' predictors ' and longitudinal ' targets '. Neuropsychopharmacology , 38, 377-385.
22. Cattaneo, A., Sesta, A., Calabrese, F., Nielsen, G., Riva, M.A. & Gennarelli, M. (2013). The expression of VGF is reduced in leucocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology, 35, 1423-1428.
23. Dantzer, R., O ' Connor, J.C., Freund, G.G., Johnson, R.W. & Kelley, K.W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46-56.
24. de Kloet, E. R., Joels, M. & Holsboer, F. (2005). Stress and the brain: From adaptation to disease. Nature Reviews Neuroscience, 6, 463-475.
25. Dermitzakis, E.T. & Stranger, B.E. (2006). Genetic variation in human gene expression. Mammalian Genome, 17, 503-508.
26. Dome, P., Teleki, Z., Rihmer, Z., Peter, L., Dobos, J., Kenessey, I., ? Dome, B. (2009). Circulating endothelial progenitor cells and depression: A possible novel link between heart and soul. Molecular Psychiatry, 14, 523-531.
27. Dumeaux, V., Lund, E. & Borresen-Dale, A.-L. (2008). Comparison of globin RNA processing methods for genomewide transcriptome analysis from whole blood. Biomarkers in Medicine, 2, 11-21.
28. Dunn, A.J., Swiergiel, A.H. & de Beaurepaire, R. (2005). Cytokines as mediators of depression: What can we learn from animal studies? Neuroscience and Biobehavioral Reviews, 29, 891-909.
29. Engel, D., Zomkowski, A.D., Lieberknecht, V., Rodrigues, A.L. & Gabilan, N.H. (2013). Chronic administration of duloxetine and mirtazapine downregulates proapoptotic proteins and upregulates neurotrophin gene expression in the hippocampus and cerebral cortex of mice. Journal of Psychiatric Research, 47, 802-808.
30. Fava, M. & Kendler, K.S. (2000). Major depressive disorder. Neuron, 28, 335-341.
31. Franchini, L., Serretti, A., Gasperini, M. & Smeraldi, E. (1998). Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. Journal of Psychiatric Research, 32, 255-259.
32. Ganea, K., Menke, A., Schmidt, M.V., Lucae, S., Rammes, G., Liebl, C., ? Muller, M.B. (2012). Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response. Translational Psychiatry, 2, e177.
33. Garriock, H.A., Kraft, J.B., Shyn, S.I., Peters, E.J., Yokoyama, J.S., Jenkins, G.D., ? Hamilton, S.P. (2010). A genomewide association study of citalopram response in major depressive disorder. Biological Psychiatry, 67, 133-138.
34. GENDEP, MARS & STAR D Investigators. (2013). Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacog enetic studies. American Journal of Psychiatry, 170, 207-217.
35. Gerhold, D.L., Jensen, R.V., Gullans, S.R. (2002). Better therapeutics through microarrays. Nat Genet, 32, 547-551.
36. Hennings, J.M., Owashi, T., Binder, E.B., Horstmann, S., Menke, A., Kloiber, S., ? Lucae, S. (2009). Clinical characteristics and treatment outcome in a representative sample of depressed inpatients-Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research, 43, 215-229.
37. Holsboer, F. (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 23, 477-501.
38. Holsboer, F. (2008). How can we realize the promise of personalized antidepressant medicines? Nature Reviews Neuroscience, 9, 638-646.
39. Huang, E.J. & Reichardt, L.F. (2001). Neurotrophins: Roles in neuronal development and function. Annual Review of Neuroscience, 24, 677-736.
40. Iga, J., Ueno, S., Yamauchi, K., Motoki, I., Tayoshi, S., Ohta, K., ? Ohmori, T. (2005). Serotonin transporter mRNA expression in peripheral leucocytes of patients with major depression before and after treatment with paroxetine. Neuroscience Letters, 389, 12-16.
41. Iga, J., Ueno, S., Yamauchi, K., Numata, S., Kinouchi, S., Tayoshi-Shibuya, S., ? Ohmori, T. (2007). Altered HDAC5 and CREB mRNA expressions in the peripheral leucocytes of major depression. Progress in Neuro-psychopharmacology and Biological Psychiatry, 31, 628-632.
42. Iga, J., Ueno, S., Yamauchi, K., Numata, S., Tayoshi-Shibuya, S., Kinouchi, S., ? Ohmori, T. (2007). Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Progress in Neuro-psychopharmacology and Biological Psychiatry, 31, 658-663.
43. Illumina. (2010). Technical Note. Retrieved from http://www. illumina.com/Documents/products/technotes/technote-gene-expression-data-quality- control.pdf
44. Ising, M., Lucae, S., Binder, E.B., Bettecken, T., Uhr, M., Ripke, S., ? Muller-Myhsok, B. (2009). A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Archives of General Psychiatry, 66, 966-975.
45. Kalman, J., Palotas, A., Juhasz, A., Rimanoczy, A., Hugyecz, M., Kovacs, Z., ? Puskas, L.G. (2005). Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression-Evolution of antidepressants and the role of the ' neuro-immune ' system. Neurochemical Research, 30, 1429-1438.
46. Kato, M. & Serretti, A. (2010). Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Molecular Psychiatry, 15, 473-500.
47. Katz, E.R., Stowe, Z.N., Newport, D.J., Kelley, M.E., Pace, T.W., Cubells, J.F. & Binder, E.B. (2012). Regulation of mRNA expression encoding chaperone and co-chaperone proteins of the glucocorticoid receptor in peripheral blood: Association with depressive symptoms during pregnancy. Psychological Medicine, 42, 943-956.
48. Keller, M.C. & Miller, G. (2006). Resolving the paradox of common, harmful, heritable mental disorders: Which evolutionary genetic models work best? Behavioral and Brain Sciences, 29, 385-404 ; discussion 405-352.
49. Kockx, M., Jessup, W. & Kritharides, L. (2008). Regulation of endogenous apolipoprotein E secretion by macrophages. Arteriosclerosis Thrombosis and Vascular Biology, 28, 1060-1067.
50. Kurian, S.M., Le-Niculescu, H., Patel, S.D., Bertram, D., Davis, J., Dike, C., ? Niculescu, A.B. (2011). Identification of blood biomarkers for psychosis using convergent functional genomics. Molecular Psychiatry, 16, 37-58.
51. Le-Niculescu, H., Case, N.J., Hulvershorn, L., Patel, S.D., Bowker, D., Gupta, J., ? Niculescu, A.B. (2011). Convergent functional genomic studies of omega-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Translational Psychiatry, 1, e4.
52. Le-Niculescu, H., Kurian, S.M., Yehyawi, N., Dike, C., Patel, S.D., Edenberg, H.J., ? Niculescu, A.B. (2009). Identifying blood biomarkers for mood disorders using convergent functional genomics. Molecular Psychiatry, 14, 156-174.
53. Lee, J.H., Ko, E., Kim, Y.E., Min, J.Y., Liu, J., Kim, Y., ? Bae, H. (2010). Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray. BMC Neuroscience, 11, 152.
54. Leek, J.T., Scharpf, R.B., Bravo, H.C., Simcha, D., Langmead, B., Johnson, W.E., ? Irizarry, R.A. (2010). Tackling the widespread and critical impact of batch effects in high-throughput data. Nature Reviews Genetics, 11, 733-739.
55. Li, X., Frye, M.A. & Shelton, R.C. (2012). Review of pharmacological treatment in mood disorders and future directions for drug development. Neuropsychopharmacology, 37, 77-101.
56. Liew, C.C., Ma, J., Tang, H.C., Zheng, R. & Dempsey, A.A. (2006). The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. Journal of Laboratory and Clinical Medicine, 147, 126-132.
57. Liu, J., Walter, E., Stenger, D. & Thach, D. (2006). Effects of globin mRNA reduction methods on gene expression profiles from whole blood. Journal of Molecular Diagnostics, 8, 551-558.
58. Malki, K., Uher, R., Paya-Cano, J., Binder, E., Rietschel, M., Zobel, A., ? Schalkwyk, L.C. (2011). Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological Psychiatry, 69, 360-365.
59. Mamdani, F., Berlim, M.T., Beaulieu, M.M., Labbe, A., Merette, C. & Turecki, G. (2011). Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Translational Psychiatry, 1, e13.
60. Mamdani, F., Berlim, M.T., Beaulieu, M.M. & Turecki, G. (2013). Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder. World Journal of Biological Psychiatry, [Epub ahead of print].
61. Matsubara, T., Funato, H., Kobayashi, A., Nobumoto, M. & Watanabe, Y. (2006). Reduced glucocorticoid receptor alpha expression in mood disorder patients and first-degree relatives. Biological Psychiatry, 59, 689-695.
62. McGuffin, P., Cohen, S. & Knight, J. (2007). Homing in on depression genes. American Journal of Psychiatry, 164, 195-197.
63. Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., ? Binder, E.B. (2011). Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: Evidence from endocrine and gene expression studies. Archives of General Psychiatry, 68, 901-910.
64. Mehta, D., Menke, A. & Binder, E.B. (2010). Gene expression studies in major depression. Current Psychiatry Reports, 12, 135-144.
65. Menke, A., Arloth, J., Putz, B., Weber, P., Klengel, T., Mehta, D., ? Binder, E.B. (2012). Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuro psychopharmacology, 37, 1455-1464.
66. Menke, A. & Binder, E.B. (2011). Genetics of major depression. Psychotherapie, 16, 247-264.
67. Menke, A., Klengel, T. & Binder, E.B. (2012). Epigenetics, depression and antidepressant treatment. Current Pharmaceutical Design, 18, 5879-5889.
68. Menke, A., Klengel, T., Rubel, J., Bruckl, T., Pfister, H., Lucae, S., ? Binder, E.B. (2013). Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain and Behavior, 12, 289-296.
69. Menke, A., Rex-Haffner, M., Klengel, T., Binder, E.B. & Mehta, D. (2012). Peripheral blood gene expression: It all boils down to the RNA collection tubes. BMC Research Notes, 5, 1.
70. Morilak, D.A. & Frazer, A. (2004). Antidepressants and brain monoaminergic systems: A dimensional approach to understanding their behavioural effects in depression and anxiety disorders. International Journal of Neuropsychopharmacology , 7, 193-218.
71. Murphy, G.M., Jr, Sarginson, J.E., Ryan, H.S., O ' Hara, R., Schatzberg, A.F. & Lazzeroni, L.C. (2013). BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression. Pharmacogenetics and Genomics, 23, 301-313.
72. Nakataki, M., Iga, J., Numata, S., Yoshimoto, E., Kodera, K., Watanabe, S.Y., ? Ohmori, T. (2011). Gene expression and association analysis of the epithelial membrane protein 1 gene in major depressive disorder in the Japanese population. Neuroscience Letters, 489, 126-130.
73. Nikula, T., Mykkanen, J., Simell, O. & Lahesmaa, R. (2013). Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood. Translational Research, 161, 181-188.
74. O'Reilly, R.L., Bogue, L. & Singh, S.M. (1994). Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biological Psychiatry, 36, 467-471.
75. Otsuki, K., Uchida, S., Wakabayashi, Y., Matsubara, T., Hobara, T., Funato, H. & Watanabe, Y. (2010). Aberrant REST-mediated transcriptional regulation in major depressive disorder. Journal of Psychiatric Research, 44, 378-384.
76. Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., ? Watanabe, Y. (2008). Altered expression of neurotrophic factors in patients with major depression. Journal of Psychiatric Research, 42, 1145-1153.
77. Padmos, R.C., Hillegers, M.H., Knijff, E.M., Vonk, R., Bouvy, A., Staal, F.J., ? Drexhage, H.A. (2008). A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Archives of General Psychiatry, 65, 395-407.
78. Pajer, K., Andrus, B.M., Gardner, W., Lourie, A., Strange, B., Campo, J., ? Redei, E.E. (2012). Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Translational Psychiatry, 2, e101.
79. Palmer, T.D., Willhoite, A.R. & Gage, F.H. (2000). Vascular niche for adult hippocampal neurogenesis. Journal of Comparative Neurology, 425, 479-494.
80. Pandey, G.N., Dwivedi, Y., Rizavi, H.S., Ren, X., Zhang, H. & Pavuluri, M.N. (2010). Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Progress in Neuro-psychopharmacology and Biological Psychiatry, 34, 645-651.
81. Pare, C.M., Rees, L. & Sainsbury, M.J. (1962). Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet, 2, 1340-1343.
82. Pariante, C.M. & Miller, A.H. (2001). Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry, 49, 391-404.
83. Pilar-Cuellar, F., Vidal, R. & Pazos, A. (2012). Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, beta-catenin and antidepressant-like effects. British Journal of Pharmacology, 165, 1046-1057.
84. Pitychoutis, P.M., Dalla, C., Sideris, A.C., Tsonis, P.A. & Papadopoulou-Daifoti, Z. (2012). 5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: Sex differences exposed. Neuroscience, 210, 152-167.
85. Rocc, P., De Leo, C., Eva, C., Marchiaro, L., Milani, A.M., Musso, R., ? Bogetto, F. (2002). Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Progress in Neuropsycho pharmacology and Biological Psychiatry, 26, 1155-1160.
86. Rogoz, Z., Skuza, G. & Legutko, B. (2005). Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. Journal of Physiology and Pharmacology, 56, 661-671.
87. Rogoz, Z., Skuza, G. & Legutko, B. (2007). Repeated co-treatment with imipramine and amantadine induces hippocampal brain-derived neurotrophic factor gene expression in rats. Journal of Physiology and Pharmacology, 58, 219-234.
88. Rollins, B., Martin, M.V., Morgan, L. & Vawter, M.P. (2010). Analysis of whole genome biomarker expression in blood and brain. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 153B, 919-936.
89. Roses, A.D. (2000). Pharmacogenetics and the practice of medicine. Nature, 405, 857-865.
90. Rugulies, R. (2002). Depression as a predictor for coronary heart disease. A review and meta-analysis. American Journal of Preventive Medicine, 23, 51-61.
91. Rush, A.J., Bernstein, I.H., Trivedi, M.H., Carmody, T.J., Wisniewski, S., Mundt, J.C., ? Fava, M. (2006). An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: A sequenced treatment alternatives to relieve depression trial report. Biological Psychiatry, 59, 493-501.
92. Sani, G., Napoletano, F., Forte, A.M., Kotzalidis, G.D., Panaccione, I., Porfiri, G.M., ? Girardi, P. (2012). The Wnt pathway in mood disorders. Current Neuropharmacology, 10, 239-253.
93. Scherzer, C.R., Eklund, A.C., Morse, L.J., Liao, Z., Locascio, J.J., Fefer, D., ? Gullans, S.R. (2007). Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences of the United States of America, 104, 955-960.
94. Schurmann, C., Heim, K., Schillert, A., Blankenberg, S., Carstensen, M., Dorr, M., ? Ziegler, A. (2012). Analyzing illumina gene expression microarray data from different tissues: Methodological aspects of data analysis in the metaxpress consortium. Public Library of Science One, 7, e50938.
95. Segman, R.H., Goltser-Dubner, T., Weiner, I., Canetti, L., Galili-Weisstub, E., Milwidsky, A., ? Hochner-Celnikier, D. (2010). Blood mononuclear cell gene expression signature of postpartum depression. Molecular Psychiatry, 15, 93-100, 102.
96. Segman, R.H., Shefi, N., Goltser-Dubner, T., Friedman, N., Kaminski, N. & Shalev, A.Y. (2005). Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Molecular Psychiatry, 10, 500-513, 425.
97. Serres, F., Millan, M.J. & Sharp, T. (2011). Molecular adaptation to chronic antidepressant treatment: Evidence for a more rapid response to the novel alpha(2)-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine. International Journal of Neuropsychopharmacology, 15, 617-629.
98. Shishkina, G.T., Kalinina, T.S. & Dygalo, N.N. (2012). Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions. Cellular and Molecular Neurobiology, 32, 787-794.
99. Spijker, S., Zanten, J.S., De Jong, S., Penninx, B.W., van Dyck, R., Zitman, F.G., ? Hoogendijk, W.J. (2010). Stimulated gene expression profiles as a blood marker of major depressive disorder. Biological Psychiatry, 68, 179-186.
100. Sullivan, P.F., Fan, C. & Perou, C.M. (2006). Evaluating the comparability of gene expression in blood and brain. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 141, 261-268.
101. Sullivan, P.F., Neale, M.C. & Kendler, K.S. (2000). Genetic epidemiology of major depression: Review and meta-analysis. American Journal of Psychiatry, 157, 1552-1562.
102. Suzuki, K., Iwata, Y., Matsuzaki, H., Anitha, A., Suda, S., Iwata, K., ? Mori, N. (2010). Reduced expression of apolipoprotein E receptor type 2 in peripheral blood lymphocytes from patients with major depressive disorder. Progress in Neuro-psychopharmacology and Biological Psychiatry, 34, 1007-1010.
103. Takano, K., Yamasaki, H., Kawabe, K., Moriyama, M. & Nakamura, Y. (2012). Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes. Journal of Pharmacological Sciences, 120, 176-186.
104. Tian, Z., Palmer, N., Schmid, P., Yao, H., Galdzicki, M., Berger, B., ? Kohane, I.S. (2009). A practical platform for blood biomarker study by using global gene expression profiling of peripheral whole blood. Public Library of Science One, 4, e5157.
105. Tomita, H., Vawter, M.P., Walsh, D.M., Evans, S.J., Choudary, P.V., Li, J., ? Bunney, W.E., Jr. (2004). Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain. Biological Psychiatry, 55, 346-352.
106. Tsao, C.W., Lin, Y.S., Chen, C.C., Bai, C.H. & Wu, S.R. (2006). Cytokines and serotonin transporter in patients with major depression. Progress in Neuro-psychopharmacology and Biological Psychiatry, 30, 899-905.
107. Uher, R. (2009). The role of genetic variation in the causation of mental illness: An evolution-informed framework. Molecular Psychiatry, 14, 1072-1082.
108. Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., ? Craig, I. (2009). Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics Journal, 9, 225-233.
109. Uher, R., Perroud, N., Ng, M.Y., Hauser, J., Henigsberg, N., Maier, W., ? McGuffin, P. (2010). Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. American Journal of Psychiatry, 167, 555-564.
110. Ustun, T.B., Ayuso-Mateos, J.L., Chatterji, S., Mathers, C. & Murray, C.J. (2004). Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 184, 386-392.
111. Vartanian, K., Slottke, R., Johnstone, T., Casale, A., Planck, S.R., Choi, D., ? Harrington, C.A. (2009). Gene expression profiling of whole blood: Comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics, 10, 2.
112. Weeber, E.J., Levenson, J.M. & Sweatt, J.D. (2002). Molecular genetics of human cognition. Molecular Interventions, 2, 376-391, 339.
113. Weigelt, K., Carvalho, L.A., Drexhage, R.C., Wijkhuijs, A., de Wit, H., van Beveren, N.J., ? Drexhage, H.A. (2011). TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors. Brain Behavior and Immunity, 25, 1162-1169.
114. Whitney, A.R., Diehn, M., Popper, S.J., Alizadeh, A.A., Boldrick, J.C., Relman, D.A. & Brown, P.O. (2003). Individuality and variation in gene expression patterns in human blood. Proceedings of the National Academy of Sciences of the United States of America, 100, 1896-1901.
115. Wulf, P. & Suter, U. (1999). Embryonic expression of epithelial membrane protein 1 in early neurons. Developmental Brain Research, 116 (2), 169-180.
116. Yehuda, R., Cai, G., Golier, J.A., Sarapas, C., Galea, S., Ising, M., ? Buxbaum, J.D. (2009). Gene Expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biological Psychiatry, 66, 708-711.
117. Yi, Z., Li, Z., Yu, S., Yuan, C., Hong, W., Wang, Z., ? Fang, Y. (2012). Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. Public Library of Science One, 7, e31283.
118. Zubenko, G.S., Hughes, H.B., III, Maher, B.S., Stiffler, J.S., Zubenko, W.N. & Marazita, M.L. (2002). Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. American Journal of Medical Genetics, 114, 980-987.